Joshua J Neumiller

Summary

Affiliation: Washington State University
Country: USA

Publications

  1. pmc Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington
    Diabetes Metab Syndr Obes 3:215-26. 2010
  2. ncbi request reprint Incretin pharmacology: a review of the incretin effect and current incretin-based therapies
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99210 1495, USA
    Cardiovasc Hematol Agents Med Chem 10:276-88. 2012
  3. doi request reprint Review of linagliptin for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
    Clin Ther 34:993-1005. 2012
  4. doi request reprint Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    College of Pharmacy, Washington State University, Spokane, WA, USA
    Ann Pharmacother 46:358-67. 2012
  5. doi request reprint Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA
    Pharmacotherapy 30:463-84. 2010
  6. doi request reprint Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Elder Services, Washington State University, 5125 North Market Street, Spokane, WA 99217, USA
    Am J Health Syst Pharm 67:1515-25. 2010
  7. doi request reprint Pharmacologic management of the older patient with type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Am J Geriatr Pharmacother 7:324-42. 2009
  8. doi request reprint Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
    J Am Pharm Assoc (2003) 49:S16-29. 2009
  9. doi request reprint A review of inhaled technosphere insulin
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217, USA
    Ann Pharmacother 44:1231-9. 2010
  10. doi request reprint Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visits
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
    Prim Care Diabetes 3:197-9. 2009

Detail Information

Publications29

  1. pmc Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington
    Diabetes Metab Syndr Obes 3:215-26. 2010
    ..Diligent postmarketing surveillance to elucidate the risk of pancreatitis and medullary thyroid carcinoma in a heterogeneous population are likely warranted...
  2. ncbi request reprint Incretin pharmacology: a review of the incretin effect and current incretin-based therapies
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99210 1495, USA
    Cardiovasc Hematol Agents Med Chem 10:276-88. 2012
    ..While the potential benefits of incretin-based therapies in the arena of cardiovascular risk reduction are promising, results from ongoing outcomes-based studies will help determine the role of these agents in this setting...
  3. doi request reprint Review of linagliptin for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, 99210 1495, USA
    Clin Ther 34:993-1005. 2012
    ....
  4. doi request reprint Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    College of Pharmacy, Washington State University, Spokane, WA, USA
    Ann Pharmacother 46:358-67. 2012
    ..To review the pharmacology, pharmacokinetics, and clinical efficacy and safety of linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor recently approved in the US for use as a treatment for type 2 diabetes mellitus...
  5. doi request reprint Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, Washington State University, and Elder Services, Spokane, Washington 99217, USA
    Pharmacotherapy 30:463-84. 2010
    ....
  6. doi request reprint Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Elder Services, Washington State University, 5125 North Market Street, Spokane, WA 99217, USA
    Am J Health Syst Pharm 67:1515-25. 2010
    ..The pharmacology, pharmacokinetics, efficacy, safety, and dosage and administration of saxagliptin are reviewed...
  7. doi request reprint Pharmacologic management of the older patient with type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Am J Geriatr Pharmacother 7:324-42. 2009
    ....
  8. doi request reprint Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
    J Am Pharm Assoc (2003) 49:S16-29. 2009
    ..To review the pharmacology (absorption, metabolism, distribution, elimination, and contraindications) of incretin-based agents currently available and in regulatory review for the treatment of patients with type 2 diabetes...
  9. doi request reprint A review of inhaled technosphere insulin
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217, USA
    Ann Pharmacother 44:1231-9. 2010
    ..To review the pharmacology, pharmacokinetics, efficacy, safety, and clinical use of Technosphere insulin...
  10. doi request reprint Rate of obesity in U.S. ambulatory patients with diabetes mellitus: a national assessment of office-based physician visits
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, United States
    Prim Care Diabetes 3:197-9. 2009
    ..S. National Ambulatory Medical Care Survey (NAMCS). Our findings indicate a significant proportion of U.S. ambulatory patients with DM present with obesity and greater clinical acuity than patients with DM alone...
  11. doi request reprint Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, WA 99217, USA
    Ann Pharmacother 43:1433-44. 2009
    ..To review the pharmacology, pharmacokinetics, efficacy, and safety of liraglutide, a glucagon-like peptide 1 (GLP-1) analog for the treatment of type 2 diabetes mellitus...
  12. doi request reprint Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatment
    Joshua J Neumiller
    College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
    Clin Ther 33:528-76. 2011
    ....
  13. ncbi request reprint Pharmacological management of glycemic control in the geriatric patient with type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elderly Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 24:45-63. 2009
    ....
  14. doi request reprint Looking to the future: focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies
    Joshua J Neumiller
    PharmD, Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, 5125 North Market Street, Spokane, WA 99217, USA
    Diabetes Educ 34:183-200. 2008
    ..This article, part 3 of a 3-part series, reviews the new class of medications known as DPP-4 inhibitors as well as discusses a future buccal insulin formulation, Oral-Lyn, on the horizon for the treatment of diabetes mellitus...
  15. doi request reprint Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus
    Travis E Sonnett
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Pullman, Washington 99164 6510, USA
    Clin Ther 31:245-59. 2009
    ....
  16. ncbi request reprint Inhaled dry powder insulin for the treatment of diabetes mellitus
    Stephen M Setter
    Department of Pharmacotherapy, College o f Pharmacy, Washington State University, Spokane, WA 99217 6131, USA
    Clin Ther 29:795-813. 2007
    ..Inhaled dry powder insulin (IDPI) is the first inhaled insulin approved for the treatment of type 1 and type 2 diabetes mellitus (DM)...
  17. doi request reprint Technosphere insulin: an inhaled prandial insulin product
    Joshua J Neumiller
    Department of Pharmacotherapy, Washington State University, Spokane, Washington 99210 1495, USA
    BioDrugs 24:165-72. 2010
    ..Additionally, Technosphere insulin has demonstrated a favorable safety and tolerability profile in clinical studies to date...
  18. ncbi request reprint Janumet: a combination product suitable for use in patients with Type 2 diabetes
    Jonathan Kent Reynolds
    Washington State University, College of Pharmacy, Department of Pharmacotherapy, Pullman, WA, USA
    Expert Opin Investig Drugs 17:1559-65. 2008
    ..Sitagliptin has been shown to be safe and effective at 100 mg daily doses. When given in combination with metformin the effect on glycemic control is thought to be complementary and possibly additive...
  19. doi request reprint Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, WA 99217, USA
    Am J Health Syst Pharm 66:2027-31. 2009
    ..The effectiveness of a collaborative pharmacist-nurse intervention on resolving detected medication discrepancies as patients transitioned from hospital to home health care was evaluated...
  20. doi request reprint Nurse identified hospital to home medication discrepancies: implications for improving transitional care
    Cynthia F Corbett
    College of Nursing, Washington State University, Spokane, WA, USA
    Geriatr Nurs 31:188-96. 2010
    ..Medication discrepancies were identified in virtually all classes of medications, including those with high safety risks. Evidence-based best practices to reduce transition-related medication discrepancies are presented...
  21. doi request reprint Transitional care: exploring the home healthcare nurse's role in medication management
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Elder Services, Spokane, Washington 99217 6131, USA
    Home Healthc Nurse 30:19-26. 2012
    ..Nurses must partner with pharmacists, physicians, and others involved with care transitions to decrease the likelihood of patients experiencing untoward health consequences associated with medications.-Eric A. ...
  22. doi request reprint Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia
    Megan N Willson
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington, USA
    Am J Cardiovasc Drugs 10:105-8. 2010
    ..Nevertheless, previous research suggests that there remain racial/ethnic disparities in the access to and quality of care for hyperlipidemia...
  23. ncbi request reprint Treatment of chorea associated with Huntington's disease: focus on tetrabenazine
    Stephen M Setter
    Washington State University Elder Sevices, Spokane, Washington 99217, USA
    Consult Pharm 24:524-37. 2009
    ..Review Huntington's disease (HD) and the role of tetrabenazine (TBZ) in treating chorea associated with this disease. Discuss the pharmacology, side-effect profile, drug interactions, precautions, and contraindications of TBZ...
  24. ncbi request reprint Screening for undiagnosed cognitive impairment in homebound older adults
    Stephen M Setter
    Department of Pharmacotherapy, College of Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 24:299-305. 2009
    ..To screen for undetected cognitive impairment in homebound elders receiving home health care services...
  25. doi request reprint Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus
    Joshua J Neumiller
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99217, USA
    Drugs 70:377-85. 2010
    ....
  26. ncbi request reprint Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms
    Mark W Garrison
    Department of Pharmacotherapy, College of Pharmacy, Washington State University, Spokane, Washington 99210 1495, USA
    Clin Ther 27:12-22. 2005
    ..Tigecycline is an investigational glycylcycline antibiotic that shows promising activity against these resistant gram-positive organisms...
  27. doi request reprint Can a new ultra-long-acting insulin analogue improve patient care? Investigating the potential role of insulin degludec
    Jennifer D Robinson
    Department of Pharmacotherapy, Washington State University, PO Box 646710, Pullman, WA 99164 6710, USA
    Drugs 72:2319-25. 2012
    ..This article briefly reviews current evidence for the use of insulin degludec in patients with type 1 or type 2 diabetes mellitus and discusses the potential impact of this new basal insulin on clinical practice...
  28. doi request reprint Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
    Lindy D Wood
    Elder Services, Spokane, Washington, USA
    Am J Geriatr Pharmacother 8:294-315. 2010
    ..The nonmotor symptoms of PD have the potential to be more debilitating than the motor features of the disorder...
  29. ncbi request reprint The Mini-Cog: a rapid dementia screening tool suitable for pharmacists' use
    Stephen M Setter
    Department of Pharmacotherapy, Colleg eof Pharmacy, Washington State University Elder Services, Spokane, Washington 99217 6131, USA
    Consult Pharm 22:855-61. 2007
    ..To familiarize the consultant pharmacist with the use of the Mini-Cog as a rapid screening tool for the assessment of dementia and outline currently available evidence regarding the validity of this screening tool within the community...